Leukemia

show blocks helper

Sort by Default

Display 15 Products per page

Disease Analysis: Acute Myeloid Leukemia (AML)
Read More
Acute myeloid leukemia (AML) is a hematological malignancy characterized by the proliferation of myeloid blast cells in blood and bone marrow.
June 15, 2020
Find out more
Market Spotlight: Acute Lymphoblastic Leukemia (ALL)

$1,318.00

Acute lymphoblastic leukemia (ALL), also known as acute lymphocytic leukemia, is a rare blood cancer characterized by rapid proliferation and accumulation of immature lymphoid cells in the bone marrow, peripheral blood, and other organs.
May 15, 2020
Find out more
Chronic Lymphocytic Leukemia (CLL)
Read More
Chronic lymphocytic leukemia (CLL) is a disease characterized by an accumulation of mature malignant B lymphocytes in the peripheral blood, bone marrow, and lymph nodes.
January 31, 2019
Find out more
Acute Lymphobastic Leukemia (ALL) Forecast and Market Analysis to 2024
Read More
Acute lymphoblastic leukemia (ALL) is a hematological disease that is characterized by the proliferation of immature lymphoid cells in the bone marrow and peripheral blood. ALL is typically a disease of childhood, with over 70% of cases affecting children.
July 5, 2018
Find out more
Chronic Myeloid Leukemia (CML)
Read More
Chronic myeloid leukemia (CML), also known as chronic myelogenous leukemia, is a myeloproliferative disorder characterized by a single cytogenetic hallmark.
December 7, 2017
Find out more

Sign up to the Pharma Intelligence Report Store Newsletter to get the latest blogs, news, reports and discounts!

Pharma Intelligence is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726

Call Back

Name

Email *

Company name *

Phone number *